CSL - Nettoeinkommen

Aktienkurs
139.19
Täglich Wechseln
-1.04 -0.74%
Monatlich
-2.38%
Jährlich
-40.28%
Q2 Prognose
136.36




Nettoeinkommen Veränderung Datum
Alterity Therapeutics Limited AUD -6.3M 525.41K 2025-12
Arca Biopharma USD -29.58M 694K 2025-12
aTyr Pharma USD 24.56M 50.3M 2025-12
Bio Path USD -976K 3.62M 2025-09
Brainstorm Cell Therapeutics USD -2.11M 797K 2025-09
Cara Therapeutics USD -5.53M 621K 2025-09
CSL USD 401M 96.5M 2025-12
Curis USD 19.36M 31.16M 2025-12
Esperion Therapeutics USD 61.83M 93.16M 2025-12
Immunic USD -24.37M 2.99M 2024-09
Infinity Pharmaceuticals USD -9.96M 1.09M 2023-06
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Sangamo BioSciences USD -36.13M 12.96M 2024-06
TherapeuticsMD USD -1.09M 356K 2024-06